{"id":"https://openalex.org/W1970347994","doi":"https://doi.org/10.1016/s0166-3542(99)00010-8","title":"Resistance mutations selected in vivo under therapy with anti-HIV drug HBY 097 differ from resistance pattern selected in vitro","display_name":"Resistance mutations selected in vivo under therapy with anti-HIV drug HBY 097 differ from resistance pattern selected in vitro","publication_year":1999,"publication_date":"1999-05-01","ids":{"openalex":"https://openalex.org/W1970347994","doi":"https://doi.org/10.1016/s0166-3542(99)00010-8","mag":"1970347994","pmid":"https://pubmed.ncbi.nlm.nih.gov/10333139"},"language":"en","primary_location":{"id":"doi:10.1016/s0166-3542(99)00010-8","doi":"https://doi.org/10.1016/s0166-3542(99)00010-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0166-3542(99)00010-8","pdf_url":null,"source":{"id":"https://openalex.org/S137372404","display_name":"Antiviral Research","issn_l":"0166-3542","issn":["0166-3542","1872-9096"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057497318","display_name":"Helga R\u00fcbsamen\u2010Waigmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"H RUBSAMENWAIGMANN","raw_affiliation_strings":["Bayer Pharma Research Center, Anti-Infectives Research, Wuppertal, Germany","Bayer Pharma Research Center, Anti-Infectives Research, Aprather Weg, 42096 Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma Research Center, Anti-Infectives Research, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Pharma Research Center, Anti-Infectives Research, Aprather Weg, 42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062844436","display_name":"Edward D. Huguenel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E HUGUENEL","raw_affiliation_strings":["Bayer Research Center, Pharmaceutical Division, 400 Morgan Lane, West Haven, CT 06516-4175, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Research Center, Pharmaceutical Division, 400 Morgan Lane, West Haven, CT 06516-4175, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061647772","display_name":"Anita Shah","orcid":"https://orcid.org/0000-0002-7846-3115","observed_orcids":["https://orcid.org/0000-0002-7846-3115"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A SHAH","raw_affiliation_strings":["Bayer Research Center, Pharmaceutical Division, 400 Morgan Lane, West Haven, CT 06516-4175, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Research Center, Pharmaceutical Division, 400 Morgan Lane, West Haven, CT 06516-4175, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023407749","display_name":"Arno Paessens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"A PAESSENS","raw_affiliation_strings":["Bayer Pharma Research Center, Anti-Infectives Research, Aprather Weg, 42096 Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma Research Center, Anti-Infectives Research, Aprather Weg, 42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113824893","display_name":"H. -J. Ruoff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"H RUOFF","raw_affiliation_strings":["Bayer Pharma Research Center, Anti-Infectives Research, Aprather Weg, 42096 Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma Research Center, Anti-Infectives Research, Aprather Weg, 42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000342463","display_name":"H VONBRIESEN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153469","display_name":"Georg Speyer Haus","ror":"https://ror.org/04xmnzw38","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210153469"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"H VONBRIESEN","raw_affiliation_strings":["Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Paul-Ehrlich-Str. 42-44, 60596 Frankfurt, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Paul-Ehrlich-Str. 42-44, 60596 Frankfurt, Germany","institution_ids":["https://openalex.org/I4210153469"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039475945","display_name":"Andreas Immelmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A IMMELMANN","raw_affiliation_strings":["Analysis GmbH, Paul-Ehrlich-Str. 42-44, 60596 Frankfurt, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis GmbH, Paul-Ehrlich-Str. 42-44, 60596 Frankfurt, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021773468","display_name":"Ursula Dietrich","orcid":"https://orcid.org/0000-0003-2491-4758","observed_orcids":["https://orcid.org/0000-0003-2491-4758"]},"institutions":[{"id":"https://openalex.org/I4210153469","display_name":"Georg Speyer Haus","ror":"https://ror.org/04xmnzw38","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210153469"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"U DIETRICH","raw_affiliation_strings":["Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Paul-Ehrlich-Str. 42-44, 60596 Frankfurt, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Paul-Ehrlich-Str. 42-44, 60596 Frankfurt, Germany","institution_ids":["https://openalex.org/I4210153469"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029881635","display_name":"Mark A. Wainberg","orcid":"https://orcid.org/0000-0002-0272-1317","observed_orcids":["https://orcid.org/0000-0002-0272-1317"]},"institutions":[{"id":"https://openalex.org/I4405287669","display_name":"Mark Wainberg Centre for Viral Diseases","ror":"https://ror.org/05v3dkd06","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"M WAINBERG","raw_affiliation_strings":["McGill University AIDS Centre, 3755 Cote St. Catherine Rd., Montreal, Que. H3T 1E2, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"McGill University AIDS Centre, 3755 Cote St. Catherine Rd., Montreal, Que. H3T 1E2, Canada","institution_ids":["https://openalex.org/I4405287669","https://openalex.org/I5023651"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5057497318"],"corresponding_institution_ids":["https://openalex.org/I67348948"],"apc_list":{"value":4160,"currency":"USD","value_usd":4160},"apc_paid":null,"fwci":0.9821,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.76069823,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"42","issue":"1","first_page":"15","last_page":"24"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.7680000066757202},{"id":"https://openalex.org/keywords/hiv-1-resistance-mutations","display_name":"HIV-1 resistance mutations","score":0.8159999847412109},{"id":"https://openalex.org/keywords/k103n-mutation","display_name":"K103N mutation","score":0.8870000243186951},{"id":"https://openalex.org/keywords/azt-resistance","display_name":"AZT resistance","score":0.7179999947547913},{"id":"https://openalex.org/keywords/quinoxaline-derivatives","display_name":"quinoxaline derivatives","score":0.8040000200271606},{"id":"https://openalex.org/keywords/ic50-determination","display_name":"IC50 determination","score":0.6060000061988831},{"id":"https://openalex.org/keywords/viral-suppression","display_name":"viral suppression","score":0.6119999885559082},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.7329999804496765}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6752371788024902},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6101402044296265},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.5752471089363098},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.5675239562988281},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.5671733021736145},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5521187782287598},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5473605990409851},{"id":"https://openalex.org/C182707283","wikidata":"https://www.wikidata.org/wiki/Q7315622","display_name":"Resistance mutation","level":5,"score":0.51772540807724},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.4801004230976105},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.47601112723350525},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.462078332901001},{"id":"https://openalex.org/C2778080818","wikidata":"https://www.wikidata.org/wiki/Q1788422","display_name":"Cross-resistance","level":2,"score":0.4513777494430542},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.33564019203186035},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.20208308100700378},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10545578598976135},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.09961333870887756}],"mesh":[{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004352","descriptor_name":"Drug Resistance, Microbial","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0166-3542(99)00010-8","doi":"https://doi.org/10.1016/s0166-3542(99)00010-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0166-3542(99)00010-8","pdf_url":null,"source":{"id":"https://openalex.org/S137372404","display_name":"Antiviral Research","issn_l":"0166-3542","issn":["0166-3542","1872-9096"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Research","raw_type":"journal-article"},{"id":"pmid:10333139","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10333139","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral research","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W338342353","https://openalex.org/W1635485592","https://openalex.org/W1907128970","https://openalex.org/W1963967933","https://openalex.org/W1970335365","https://openalex.org/W1973254785","https://openalex.org/W1973398091","https://openalex.org/W1989692384","https://openalex.org/W1997330869","https://openalex.org/W2004486955","https://openalex.org/W2008954911","https://openalex.org/W2009581957","https://openalex.org/W2010937018","https://openalex.org/W2016564963","https://openalex.org/W2020760853","https://openalex.org/W2022098233","https://openalex.org/W2030545030","https://openalex.org/W2032308407","https://openalex.org/W2039825890","https://openalex.org/W2040620437","https://openalex.org/W2048776156","https://openalex.org/W2062755299","https://openalex.org/W2068705423","https://openalex.org/W2079935130","https://openalex.org/W2083663238","https://openalex.org/W2090137444","https://openalex.org/W2104117639","https://openalex.org/W2114279162","https://openalex.org/W2115853658","https://openalex.org/W2117784959","https://openalex.org/W2118732329","https://openalex.org/W2130516256","https://openalex.org/W2137262613","https://openalex.org/W2149654163","https://openalex.org/W2151963339","https://openalex.org/W2163828009","https://openalex.org/W2318707910","https://openalex.org/W2343658917","https://openalex.org/W2411525232","https://openalex.org/W2415335215","https://openalex.org/W2517898186"],"related_works":["https://openalex.org/W2030545030","https://openalex.org/W2090137444","https://openalex.org/W2072320892","https://openalex.org/W2020760853","https://openalex.org/W2560352294","https://openalex.org/W2104475498","https://openalex.org/W2068389984","https://openalex.org/W8217570","https://openalex.org/W2024661749","https://openalex.org/W1999365461"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}